Sean Saint

President, CEO & Board Member

Sean Saint, P.E. is an engineer, entrepreneur, diabetes technologist and innovator, and person with type 1 diabetes. After his diagnosis with type 1 diabetes, he founded Companion Medical, where they developed and launched the InPen system, the first FDA-cleared smart pen. Medtronic acquired Companion Medical in 2020. Prior to Companion Medical, Sean was an early employee at Dexcom and Tandem Diabetes Care. Sean earned a Bachelor of Science degree in Mechanical Engineering from California Polytechnic State University – San Luis Obispo and is a registered Professional Engineer in California. He has over 175 issued and pending patent applications.

Beta Bionics is a people-focused company dedicated to making diabetes easier for everyone, every day.

Safety Information – The iLet Bionic Pancreas System is indicated for use by people with type 1 diabetes 6 years of age and older. The iLet Bionic Pancreas requires prescription by a physician. Refer to the iLet Bionic Pancreas System User Guide at www.betabionics.com/user-resources, or for complete safety information including indications, contraindications, warnings, cautions, compatible devices, compatible drugs and instructions, refer to www.betabionics.com/safety. DO NOT start to use the iLet Bionic Pancreas System without adequate training. Incorrect use may result in over-delivery or under-delivery of insulin, which could lead to hypoglycemia or hyperglycemia.

Medical Disclaimer – This website is for information only and is not a substitute for medical advice and/or services from a healthcare provider. All personal health care decisions and treatment should be discussed with a healthcare provider who is familiar with your individual needs.